Family factors have been reported to influence the course of schizophrenia. In a replication of British studies, schizophrenic patients from the Los Angeles area were evaluated for symptomatic relapse 9 months after hospital discharge as a function of the level of "expressed emotion" in their relatives. In striking confirmation of the British findings, patients who came from families that were excessively critical, emotionally overinvolved, or both were much more likely to relapse than their counterparts who came from more tolerant and accepting families.
Although medication has been effective in reducing the duration of inpatient treatment for schizophrenia, serial admissions and relapse continue to dominate the lives of schizophrenic patients. Thus, interest has burgeoned concerning the influence of social and family factors and their association with symptomatic relapse and hospital readmission.
British studies on the influence of social and family factors on the course of schizophrenia have shown that symptomatic relapse is most likely if a patient lives with relatives who are characterized as being high on "expressed emotion" (EE). High EE reflects critical, hostile, and/or overprotective attitudes toward the patient. High EE is coded from in-depth, reliably rated interviews of family members at the time of a patient's hospitalization and, hence, serves as a predictor of risk for relapse. Patients whose relatives were high on EE were four times more likely to relapse during the 9 months following hospital discharge than patients whose relatives were rated as more accepting and less intertwined (Brown, Birley, and Wing 1972; Vaughn and Leff 1976) .
At the Camarillo/UCLA Mental Health Clinical Research Center for the Study of Schizophrenia, a replication of the British work on EE was carried out with a sample of "Anglo" patients and families from the Los Angeles area. Like the British work, patients were diagnosed as schizophrenic on the basis of the Present State Examination and CATEGO criteria. Then, based on a standardized interview, the scales of EE-criticism, hostility, and overinvolvement-were rated for relatives of 54 recently hospitalized schizophrenics. Patients were closely followed for 9 months after discharge and rated monthly for relapse or exacerbation of symptoms.
Results of the study have confirmed the British findings of a significant association of patients living in high EE families and symptomatic relapse; in fact, the similarity of the data between England and California is striking (see table 1 ). Fifty-six percent of patients with a high EE relative suffered symptomatic relapse in the 9-month followup period, while only 17 percent of patients without a high EE relative relapsed.
As in the British studies, patients from high EE families who took neuroleptic medication regularly throughout the 9-month Reprint requests should be sent to Dr. R.P. Liberman, Rehabilitation Research and Training Center in Mental Illness, Brentwood VA Medical Center, 11301 Wilshire Blvd., Los Angeles, CA 90073. Those patients in the sample of 54 who lived with key relatives continuously during 9-month followup period.
followup period relapsed at a significantly lower rate than those who did not take medication regularly. In the low EE group there was no statistically significant difference in rates of relapse between the subgroups of patients who did and did not take regular medication. There were some notable differences between the English and California subjects. In London, a majority of the families were rated low on EE, while in the California sample only one-third of the families were rated low on EE. Ratings of hostility were also significantly more common in the California families. Thus, while cultural differences may produce differing distributions of high vs. low EE in families containing a schizophrenic member, the pattern of high EE retains its predictive importance cross-culturally. It was also noted that many more of the California schizophrenic patients sustained high levels of schizophrenic symptoms continuously from the time of admission, through discharge, and to the 9-month followup point. Since these patients were at a ceiling level for schizophrenic symptoms, they were not included in the analysis. Continued followup is being carried out to ascertain patients' psychiatric status at 2 years postdischarge and its relationship to EE.
